Glaucoma is a chronic, neurodegenerative disease that
is the second most common cause of blindness in the
world. All available treatment is focused on lowering IOP
to slow the progression of the disease, with no current
therapy to reverse visual field loss or improve visual acuity
available. Therefore, in this article, the authors describe
the use of high dose omega‐3 fatty acids to combat
the neuro‐inflammation in glaucoma patients, thereby
improving visual acuity and visual field in glaucoma patients. Full Text paper attached.
Only registered users have access to the most valuable content of the FitEyes community: Blogs, Comments, FitEyes Discussion Group Archives, unique information on self-tonometry and other user-generated research.
You must register because we have content that cannot be viewed unless you agree to our terms and conditions.